Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ingrid E H Kremer"'
Autor:
Ingrid E H Kremer, Silvia M A A Evers, Peter J Jongen, Trudy van der Weijden, Ilona van de Kolk, Mickaël Hiligsmann
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0164862 (2016)
Understanding the preferences of patients with multiple sclerosis (MS) for disease-modifying drugs and involving these patients in clinical decision making can improve the concordance between medical decisions and patient values and may, subsequently
Externí odkaz:
https://doaj.org/article/982b72ab86a5436eb92da395c4fb6f5c
Publikováno v:
Pharmacoeconomics
Background Although the economic burden of multiple sclerosis (MS) in high-income countries (HICs) has been extensively studied, information on the costs of MS in low- and middle‐income countries (LMICs) remains scarce. Moreover, no review synthesi
Autor:
Jean-Yves Reginster, Nannan Li, Annelies Boonen, Sandrine P. G. Bours, D. Cornelissen, Mickaël Hiligsmann, Daniel Pinto, Ingrid E. H. Kremer, Joop P. W. van den Bergh, Silvia M. A. A. Evers, Lei Si, Stuart G. Silverman, Robin T. A. L. de Bot
Publikováno v:
Pharmacoeconomics
Background Considering the heavy economic burden of osteoporotic fractures, the limits of healthcare resources, and the recent availability of new anti-osteoporosis drugs, there is continuing interest in economic evaluation studies of osteoporosis ma
Autor:
Marita Zimmermann, Mickaël Hiligsmann, Xavier Pouwels, Ingrid E. H. Kremer, Nick Bansback, Svenja Petersohn, Silvia M. A. A. Evers, Josh J. Carlson, Peter Joseph Jongen
Publikováno v:
Medical Decision Making, 40(8), 1003-1019. SAGE Publications Inc.
Medical decision making, 40(8), 1003-1019. SAGE Publications
Medical Decision Making
Medical decision making, 40(8), 1003-1019. SAGE Publications
Medical Decision Making
Background Up to 31% of patients with relapsing-remitting multiple sclerosis (RRMS) discontinue treatment with disease-modifying drug (DMD) within the first year, and of the patients who do continue, about 40% are nonadherent. Shared decision making
Autor:
Silvia M. A. A. Evers, Mickaël Hiligsmann, Ingrid E. H. Kremer, Caroline Daccache, Hala Darwish, Rana Rizk, Samia J. Khoury, Jalal Dahham
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research, 22(5), 869-876. Routledge/Taylor & Francis Group
This protocol describes the estimation of the societal costs and quality-of-life (QOL) burden of multiple sclerosis (MS) in Lebanon. This cross-sectional, prevalence-based burden-of-illness study was carried out in a premier MS center in Lebanon. We
Autor:
Silvia M. A. A. Evers, P. J. Jongen, W. I. M. Verhagen, E. L. J. Hoogervorst, Mickaël Hiligsmann, Ingrid E. H. Kremer
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-18 (2021)
BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making, 21(1):123. BioMed Central Ltd
BMC Medical Informatics and Decision Making, 21(1):123. BioMed Central Ltd.
BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making, 21(1):123. BioMed Central Ltd
BMC Medical Informatics and Decision Making, 21(1):123. BioMed Central Ltd.
Background Since decision making about treatment with disease-modifying drugs (DMDs) for multiple sclerosis (MS) is preference sensitive, shared decision making between patient and healthcare professional should take place. Patient decision aids coul
Autor:
Huub Creemers, Edith A. V. Hagedoren, Uta Roentgen, Loek A. van der Heide, Ingrid E. H. Kremer, Ramon Daniëls, M.A. Brehm, Silvia M. A. A. Evers, Jan T. Groothuis
Publikováno v:
Technology and Disability, 33(3), 207-220. IOS Press BV
Technology and Disability, 33, 207-220
Technology and Disability, 33(3), 207-220. IOS Press
Technology and Disability, 2021(33), 207-220
Technology and Disability, 33, pp. 207-220
Technology and Disability, 33, 207-220
Technology and Disability, 33(3), 207-220. IOS Press
Technology and Disability, 2021(33), 207-220
Technology and Disability, 33, pp. 207-220
BACKGROUND: Impaired upper extremity function due to muscle paresis or paralysis has a major impact on independent livingand quality of life (QoL). Assistive technology (AT) for upper extremity function (i.e. dynamic arm supports and robotic arms) ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c37931303f9ba4d558bee4b6477809
https://doi.org/10.3233/TAD-210335
https://doi.org/10.3233/TAD-210335
Autor:
Ingrid E. H. Kremer
Developments in the medication for MS give patients with MS new opportunities to slow down the progression of the disease, but also make it more difficult to determine an appropriate medication for the patient. Active participation of MS patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56531cce81d263e3af88dbbf0ea947f3
https://cris.maastrichtuniversity.nl/en/publications/9ffb32e0-c72a-4bba-8738-b12110f3d7c3
https://cris.maastrichtuniversity.nl/en/publications/9ffb32e0-c72a-4bba-8738-b12110f3d7c3
Publikováno v:
Health Expectations, 21(1), 171-180. Wiley
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Background The choice between disease-modifying drugs (DMDs) for the treatment of multiple sclerosis (MS) becomes more often a shared decision between the patient and the neurologist and MS nurse. This study aimed to assess which DMD attributes are m
Autor:
G. van den Berg, Mickaël Hiligsmann, Ingrid E. H. Kremer, Silvia M. A. A. Evers, D. Kann-Weedage, Carmen D. Dirksen
Publikováno v:
Kind en adolescent, 38(1), 1-30. Springer
Hoewel de kennis over de effectiviteit van interventies in het jeugddomein aanzienlijk is, lijkt de kennis over hun kosteneffectiviteit beperkt. Een systematische literatuurreview naar economische evaluatiestudies is uitgevoerd om de huidige kennis o